ICPerMed is happy to announce the publication
of the Strategic
Research and Innovation Agenda (SRIA) for
Personalised Medicine (PM). This SRIA
will support a wide range of stakeholders and
experts to further develop programs, activities,
and research towards PM and care, as well as
prevention. In line with this mission, its main
intention is to support the planned new European
Partnership for Personalised Medicine (EP PerMed).
The SRIA aims to ensure that the long-term vision
of EP PerMed is translated into tailored roadmaps
with funding and supporting activities, objectives
and measurable outcomes. Therewith, the SRIA
complements the EP PerMed proposal that has
recently been submitted to the European Commission
(EC).
The SRIA was developed by a dedicated
drafting group, composed of
Member States’ representatives and in close
collaboration with the EC. The drafting group was
established in 2021 in order to support the first
phase of the EP PerMed preparations, i.e. the
development of a draft
proposal for EP PerMed, that was published by
the EC in February 2022, and the SRIA for
PM.
The structure and content of the SRIA is based
on the drafting group members’ knowledge, existing
strategic documents, and further available
information. Even more importantly, it presents
the outcome of several activities and events of
which some were organised with the support of the
EC, the International Consortium for Personalised
Medicine (ICPerMed), and connected consortia like
the European Research Area Network for
Personalised Medicine (ERA PerMed).
Among these activities were interviews with
more than 70 experts and stakeholders to gather
general ideas, recommendations, and information
related to PM and, particularly, to identify so
called “Triplets of Action”,
short “ToA”, defining concrete challenges,
objectives, and the expected outcome of actions to
foster PM research and implementation of
innovative PM approaches. These ToAs are the core
elements of the SRIA. They are presented along the
main areas crucial for an effective development of
PM, also called the value continuum:
“interdisciplinary research and development
efforts”, “successful innovation” and finally,
“implementation of PM approaches into healthcare”.
Further ToAs were identified for “overarching
activities” to support PM development and
implementation.
The first set of 47 identified ToAs was
validated in an online
consultation (November -December 2022),
supported by ICPerMed. The drafting group utilised
the findings and suggestions to further refine the
SRIA. The results have been published as a report
on the ICPerMed website and the ERA PerMed website
in March 2023.
Together with ICPerMed, an expert
workshop was arranged in Pamplona in
January 2023. This event was dedicated to topics
and areas crucial for the development and
implementation of PM approaches based on
interdisciplinary research achievements and has
been a significant contribution to the SRIA. A report
summarising this workshop has recently been
published on the ICPerMed website. |